AR
VC

ARPA-H

United Statesarpa-h.gov

ARPA-H is a venture capital firm based in the United States, investing in Healthcare & Life Sciences, Cell Therapy and Inflammation, 2 tracked investments.

2
Investments Tracked

About ARPA-H

ARPA-H is a venture capital firm headquartered in the United States. We have recorded 2 investments for ARPA-H to date.

Sector activity concentrates in Healthcare & Life Sciences, Cell Therapy, Inflammation and Oncology & Cancer Treatment. Coverage extends to 8 sectors in total. Participation spans Seed and Series B rounds.

ARPA-H invests in breakthrough technologies and broadly applicable platforms to transform medicine and health. The agency supports high-impact solutions to health challenges that cannot be readily accomplished through traditional research or commercial activity.

Investment Focus

Stage Focus
seedseries-b
Sectors
Healthcare & Life Sciencescell therapyinflammationOncology & Cancer Treatmentpharmaceutical-developmentstem cellsbiotechdrug-development

Investment Thesis

ARPA-H invests in breakthrough technologies and broadly applicable platforms to transform medicine and health. The agency supports high-impact solutions to health challenges that cannot be readily accomplished through traditional research or commercial activity.

Team

Alicia JacksonDirector
Rafid FadulAssuming some duties of ARPA-H Deputy Director, Chief Medical Officer
Maxwell WatkinsChief of Staff
Keith MartinActing Director, Division of Administration and Management and Senior Advisor
Rehana MohammedInterim Executive Secretary and Senior Advisor
Benjamin BryantActing Director, Business Innovation Division
Stas BlaushildActing Deputy Director, Business Innovation Division
Carmelita Chadwick-GalloDirector, Comptroller Division
Etaf KhanActing Deputy Director, Comptroller Division
Amy LinActing Director, Division of International Affairs
Jen CamaDirector, Division of Government Relations and Strategy
Dan BarryGeneral Counsel, ARPA-H

Explore ARPA-H's full profile on Brouky

Portfolio companies, co-investors, AI match scores, and deal flow signals.

Other Investors in United States

Other Investors in Healthcare & Life Sciences / Cell Therapy